Shenzhen Hank Bioengineering Institute Report issue

Government Phase 2
Founded: Shenzhen China (2013)

Organization Overview

First Clinical Trial
2016
NCT02853903
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now